Items with tag "regulatory"
News
Ablynx' caplacizumab receives fast track designation from FDA
The fast track designation would allow caplacuzimab to enter the market 6 to 10 months earlier
Insights
Battling antibiotic resistance: are we ready for a bacteriophage revival?
The discovery of antibiotics fundamentally changed healthcare in the 20th century. Deadly infections suddenly became treatable and millions of lives were saved. But excessive antibiotic use in bot…
Microbiome regulations from an EU start-up's perspective
Interested in the microbiome? So are we! Here’s a sneak-peek into S-Biomedic, one of the first microbiome start-ups in Belgium. We asked her to tell us about the challenge of being a new company d…
What’s next for CRISPR crops in the EU?
Genetically Modification Organisms (GMOs) is one of the most hotly debated topics in the news today. Resistance to GMOs has in the past been huge and strict regulations have followed. In July this…
The power of big data constricted by law?
Huge amounts of data, including personal data, are currently being created. If we are to believe IBM, 90% of the existent data today was created in the last two years. Big data presents extremely …
Help! First aid for the Nagoya Protocol
The Nagoya Protocol, an international agreement concerning the utilization of genetic resources, entered into force more than a year ago. However, the compliance obligations and even the existence…
How to protect a country’s genetic resources ?
The Nagoya Protocol might ring a bell, but few people know exactly what it stands for. Many biotech companies develop products and processes in which a specific kind of microbe, seed or enzyme (or…
VC Views
Are tech investments under threat by anti-science sentiments?
In biotech, company creation is usually preceded by scientific discoveries presenting solutions to existing problems. Because of this, early stage VC investment is, at its core, a science-driven a…
